3 dimensional HYAFF® (hyaluronic acid ester) matrix
Transparent Silicone Membrane
The HYAFF matrix allows cellular invasion by fibroblasts or endothelial cells
HYALOMATRIX® is indicated for the management of wounds including: partial and full-thickness wounds; second-degree burns; pressure ulcers; venous ulcers; diabetic ulcers; chronic vascular ulcers; tunneled/undetermined wounds; surgical wounds (donor sites/grafts, Post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence); trauma wounds (abrasions, lacerations, skin tears); and draining wounds. The device is intended for one-time use.
|Hyalomatrix Brochure||Recommendations for use|
|Case Study - Basal cell carcinoma of scalp||Case Study - Frostbite|
|Case Study - Post-amputation lesion||Case Study - Post-traumatic lesion on forearm|
|Case Study - Arterial ulcer||Case Study - Venous ulcer|
|Case Study - Burn, 6 year old girl||Case Study - Burn, left hand|
See Hyalomatrix in use on YouTube.
1 Costigliola, M. and Agrosì, M. Second-degree burns: a comparative, multicenter, randomized trial of hyaluronic acid plus silver sulfadiazine vs silver sulfadiazine alone. Curr Med Res & Opin, 2005; 21(8):1235-1240
2 Ortonne, J.P. A controlled study of the activity of Hyaluronic acid in the treatment of venous leg ulcers. J Dermatol Treat (1996);7:75-81.
Hyalomatrix is contraindicated for patients with the individual hypersensitivity to hyluronan and/or its derivatives and silicone. Hyalomatrix does not possess bacteriostatic or bactericidal properties and should not be used on infected wounds. Remove Hyalomatrix if wound infection is confirmed. Single use only.